Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial.
Iijima K, Sako M, Oba MS, Ito S, Hataya H, Tanaka R, Ohwada Y, Kamei K, Ishikura K, Yata N, Nozu K, Honda M, Nakamura H, Nagata M, Ohashi Y, Nakanishi K, Yoshikawa N; Japanese Study Group of Kidney Disease in Children. Iijima K, et al. Among authors: sako m. Clin J Am Soc Nephrol. 2014 Feb;9(2):271-8. doi: 10.2215/CJN.13071212. Epub 2013 Nov 21. Clin J Am Soc Nephrol. 2014. PMID: 24262503 Free PMC article. Clinical Trial.
[Treatment guidelines for the idiopathic nephrotic syndrome in children].
Yoshikawa N, Honda M, Sekine K, Nakanishi K, Iijima I, Ootomo Y, Ikeda M, Wada N, Nakamura H, Sako M; Japanese Society of Nephrology Committee for Development of Guidelines for Drug Therapy for Nephrotic Syndrome in Children. Yoshikawa N, et al. Among authors: sako m. Nihon Jinzo Gakkai Shi. 2005;47(7):790-803. Nihon Jinzo Gakkai Shi. 2005. PMID: 16296409 Japanese. No abstract available.
Rituximab for refractory focal segmental glomerulosclerosis.
Nakayama M, Kamei K, Nozu K, Matsuoka K, Nakagawa A, Sako M, Iijima K. Nakayama M, et al. Among authors: sako m. Pediatr Nephrol. 2008 Mar;23(3):481-5. doi: 10.1007/s00467-007-0640-x. Epub 2007 Nov 1. Pediatr Nephrol. 2008. PMID: 17973121
Improved renal survival in Japanese children with IgA nephropathy.
Yata N, Nakanishi K, Shima Y, Togawa H, Obana M, Sako M, Nozu K, Tanaka R, Iijima K, Yoshikawa N. Yata N, et al. Among authors: sako m. Pediatr Nephrol. 2008 Jun;23(6):905-12. doi: 10.1007/s00467-007-0726-5. Pediatr Nephrol. 2008. PMID: 18224344 Free PMC article.
[Guidelines for the treatment of childhood IgA nephropathy].
Yoshikawa N, Igarashi T, Ishikura K, Kaku Y, Nakazato H, Kamei K, Kawamura T, Nakamura H, Yamamoto Y, Nakanishi K, Sako M. Yoshikawa N, et al. Among authors: sako m. Nihon Jinzo Gakkai Shi. 2008;50(1):31-41. Nihon Jinzo Gakkai Shi. 2008. PMID: 18318242 Japanese. No abstract available.
Membranous nephropathy associated with thyroid-peroxidase antigen.
Shima Y, Nakanishi K, Togawa H, Obana M, Sako M, Miyawaki M, Nozu K, Iijima K, Yoshikawa N. Shima Y, et al. Among authors: sako m. Pediatr Nephrol. 2009 Mar;24(3):605-8. doi: 10.1007/s00467-008-0973-0. Epub 2008 Sep 2. Pediatr Nephrol. 2009. PMID: 18762990
Efficacy and safety of lisinopril for mild childhood IgA nephropathy: a pilot study.
Nakanishi K, Iijima K, Ishikura K, Hataya H, Awazu M, Sako M, Honda M, Yoshikawa N; Japanese Pediatric IgA Nephropathy Treatment Study Group. Nakanishi K, et al. Among authors: sako m. Pediatr Nephrol. 2009 Apr;24(4):845-9. doi: 10.1007/s00467-008-1006-8. Epub 2008 Sep 30. Pediatr Nephrol. 2009. PMID: 18825420 Clinical Trial.
406 results